These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 17210583)
1. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia. López-Novoa JM Nephrol Dial Transplant; 2007 Mar; 22(3):712-4. PubMed ID: 17210583 [No Abstract] [Full Text] [Related]
2. Biomarker for hypertension-preeclampsia: are we close yet? Sibai BM Am J Obstet Gynecol; 2007 Jul; 197(1):1-2. PubMed ID: 17618741 [No Abstract] [Full Text] [Related]
3. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation. Sekizawa A; Purwosunu Y; Farina A; Shimizu H; Nakamura M; Wibowo N; Rizzo N; Okai T BJOG; 2010 Apr; 117(5):557-64. PubMed ID: 20121832 [TBL] [Abstract][Full Text] [Related]
4. Placental origins of angiogenic dysfunction in mirror syndrome. Bixel K; Silasi M; Zelop CM; Lim KH; Zsengeller Z; Stillman IE; Rana S Hypertens Pregnancy; 2012; 31(2):211-7. PubMed ID: 22150085 [TBL] [Abstract][Full Text] [Related]
5. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083 [TBL] [Abstract][Full Text] [Related]
7. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule. Luft FC Nephrol Dial Transplant; 2006 Nov; 21(11):3052-4. PubMed ID: 16870672 [No Abstract] [Full Text] [Related]
8. Alterations of serum and placental endoglin in pre-eclampsia. Fang M; He Y; Li H; Wu M; Shi X; Du H J Int Med Res; 2010; 38(1):43-51. PubMed ID: 20233512 [TBL] [Abstract][Full Text] [Related]
9. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Salahuddin S; Lee Y; Vadnais M; Sachs BP; Karumanchi SA; Lim KH Am J Obstet Gynecol; 2007 Jul; 197(1):28.e1-6. PubMed ID: 17618745 [TBL] [Abstract][Full Text] [Related]
11. Soluble endoglin contributes to the pathogenesis of preeclampsia. Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767 [TBL] [Abstract][Full Text] [Related]
12. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Shan HY; Rana S; Epstein FH; Stillman IE; Karumanchi SA; Williams ME Am J Kidney Dis; 2008 Jun; 51(6):1029-32. PubMed ID: 18455853 [TBL] [Abstract][Full Text] [Related]
14. The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis. de Jesus GR; de Jesus NR; Levy RA; Klumb EM Lupus; 2014 Oct; 23(12):1299-301. PubMed ID: 25228732 [TBL] [Abstract][Full Text] [Related]